Rare diseases
Investigational molecules
Locations
Back to Italy11 clinical trials in Pordenone, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research investigating the combined effects of baxdrostat and dapagliflozin in patients with chronic kidney disease and hypertension, aiming to reduce kidney failure risk and improve cardiovascular outcomes.
Studies focus on preventing sustained decline in kidney function while managing blood pressure effectively.
Advanced clinical investigations of inclisiran in treating atherosclerotic cardiovascular disease, focusing on preventing heart attacks, strokes, and cardiovascular-related mortality.
Research targets improved outcomes for patients with established vascular disease through innovative therapeutic approaches.
Evaluation of atezolizumab as a monotherapy treatment for non-small cell lung cancer, comparing its efficacy against current standard care options for post-chemotherapy patients.
Studies focus on improving survival rates and treatment outcomes in stage II-IIIA lung cancer patients.
Innovative study examining argon-based ventilation in cardiac arrest patients, investigating its potential to reduce neurological injury following successful resuscitation.
Research explores novel approaches to improve outcomes in cardiac arrest survivors through specialized ventilation techniques.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
